Savannah Resources (SAV), the developer of the Barroso Lithium Project in Portugal,, a ‘Strategic Project’ under the European Critical Raw Materials Act and Europe’s largest spodumene lithium deposit, is pleased to announce the Project’s first Ore Reserve Estimate.
The 20Mt Reserve has been estimated by Snowden Optiro from the c.27Mt of combined Measured and Indicated Resources, which form part of the Project’s overall current 39Mt JORC Compliant Resource, recently updated by Ashmore Advisory. Both the Reserve and the Resource have been prepared in accordance with the code published by the Joint Ore Reserves Committee of the Australasian Institute of Mining and Metallurgy, Australian Institute of Geoscientists and Minerals Council of Australia (The JORC Code 2012).
Comment: Shares of SAV have so far risen 73% this year, as if in anticipation of today’s milestone news. Indeed one would at least expect a retest of the best levels of the year at 7.5p by the end of next month as investors now have plenty to be excited about.
Great Southern Copper plc (GSCU), the company focused on copper-gold-silver exploration in Chile, announced an update on exploration mapping and rock chip sampling at the Viuda Negra prospect, part of the Company’s Especularita Project. GSCU said “The discovery by GSC of porphyry gold mineralisation in scout drilling at Viuda Negra last year was a significant milestone for the Company, identifying broad intervals of low-grade gold-copper associated with Maricunga-style porphyry quartz-vein stockworks. The shallow scout drilling targeted outcrops of epithermal-style alteration with anomalous gold and silver. These results build on last year’s scout drilling through further rock and channel chip sampling, indicating that the mineralised system is significantly expanded to an area covering some 500 x 700 metres. Importantly, the system remains open to the west and south, where the mineralisation appears to extend beneath shallow colluvial cover.”
Comment: Despite the continued progress the company reports on a regular basis, the shares continue to be in a 2.5p -3.5p range. One wonders what GSCU needs to do or say to break this impasse?
ECO Animal Health (EAH), a leading global animal health company developing and marketing branded veterinary products to improve livestock productivity and welfare, announced its audited results for the year ended 31 March 2026. Revenue ahead and adjusted EBITDA 4% ahead of upgraded market expectations following strong second half to the year. Group sales of £87.5m (2025: £79.6m), an increase of 10%. Adjusted EBITDA of £8.5m (2025: £7.3m), an increase of 16% and around 5% ahead of consensus.
Comment: EAH continues to progress in a pleasing way, with it being clear that demand in its niche market is continuing to blossom, as is the company’s ability to meet it. One presumes the shares are set to bottom towards the 80p zone.
EDX Medical Group (AQSE:EDX) which develops innovative digital diagnostic products and services supporting personalised treatments for major diseases, announced that it is launching a new health and wellbeing screening service in the UK which features comprehensive tests for employees. The service will involve general health checks and will also include biomarker testing panels that determine risk of cancer, cardiovascular disease and metabolic disorders.
Comment: If one had £1 for every positive initiative reported by EDX one would certainly be well on the way to a comfortable retirement. However, they are generally of the non money mentioned variety, and always feel like the prelude to another fundraise, which to be fair the market is happy to oblige on for now.
Iofina (IOF), specialists in the exploration and production of iodine and manufacturers of specialty chemical products, is pleased to provide an update regarding its activities during H1 2026. During the Period, Iofina Resources produced a record 393.3 metric tonnes (“MT”) of crystalline iodine from its eight IOsorb® plants in Oklahoma, up 29% on H1 2025 (305.5MT). The production also exceeded the Company’s previously upgraded guidance of 385MT. The record performance reflects strong operational execution across all production sites, with better-than-expected brine volumes at the Company’s central Oklahoma plants.
Comment: One of the better growth stories on the London market, from one of the better CEOs. Expect the company to continue its scaling up process, and expect the share price to continue to move to fresh highs.
Tern Plc (TERN), the company focused on value creation from Internet of Things (“IoT”) technology businesses, announces that it has raised £450,000, at a price of 0.90 pence per new Ordinary Share with an investment management group. The net proceeds of the Placing are intended to be used to provide the Company with funds to provide additional support to Tern’s portfolio as appropriate, in particular a further potential convertible loan note investment in Talking Medicines Limited, and applied towards general corporate purposes, including operating and legal expenses.
Comment: A round of applause for TERN in getting this fundraise away after the recent recovery in the shares. Alas, we know that unless something major changes for this “value creation” company, nothing will change in the prospects for long suffering shareholders.
London BTC Company Limited (BTC), the London Stock Exchange main market-listed company, is pleased to announce that it has staked 36 mineral claims at the Black Star Gold-Silver Project, in Nevada, USA. Results from initial due diligence rock chip samples collected indicate the discovery of high-grade gold at surface up to 16.23 grams per tonne (0.52 oz/t Au) and up to 50.5 g/t silver (1.62 oz/t Ag).David Lenigas, Chairman of the Company, stated: “The Black Star Project marks another exceptional development for our growing gold portfolio in the State of Nevada. Sampling from surface at Black Star has already provided evidence of high-grade gold mineralisation, with five of the nine mineralised samples grading above 8 g/t gold across two highly prospective target areas. Black Star is the fourth project staked and the third project in the strategic Northern Nevada region, sitting just 16 miles from the 16.4 million ounce Hycroft Mine. The pace at which we are building this gold portfolio speaks for itself, and I look forward to providing further updates in the coming weeks as follow-up work and additional staking get underway.“
Comment: Of course Mr Lenigas is always able to talk a good game on any company he is involved with. However, it still looks as though it is going to take time for the market to absorb the bubble in the shares that we were treated to last year, whatever and however good the news is in the interim.
Hunting PLC (HTG), the precision engineering group, today publishes its H1 2026 Trading Update. Group well positioned to navigate near-term oil price and market volatility. Robust outlook for increases in activity in Asia Pacific, the Americas and the Middle East driven by AI driven power demand, oil and gas security of supply, and changes to OPEC. 2026 full year EBITDA guidance of between $145-$155 million is maintained, with EBITDA margin guidance unchanged at c.13%-14%.
Comment: One feels that the market should be rather more loving towards HTG than it has been, and should certainly be more so in the wake of the latest update. Ideally the shares break above their 50 day line at 470p in short order and at least head back to the 500p zone, versus 470p now.
Audioboom (BOOM), the leading global podcast company, announced its unaudited half-year results for the six months ended 30 June 2026. H1 adjusted EBITDA(1) profit of US$3.2 million, up 80% on H1 2025 (US$1.8 million), highlighting the continued strong performance of the business, with adjusted EBITDA profit expected to continue to be a proxy for cash generation going forward. H1 gross profit of US$9.9 million, up 33% on H1 2025 (US$7.4 million), representing a gross margin of 22% (H1 2025: 21%). H1 revenue of US$45.7 million, up 30% on H1 2025 (US$35.1 million). Continued strong growth of Showcase – our tech-based global advertising marketplace – with H1 revenue of US$18.6 million, up 60% on H1 2025 (US$11.6 million).
Comment: We have decent jumps in the metrics for BOOM, but it may still be the case that they only justify the current 500p a share valuation than much more. We still have a bit of a hangover after the sale process debacle.
Apertura Energy Plc (VZLA), the Main Market listed acquisition company, announces the appointment of Chris Steele as a Non-Executive Director, effective immediately. His appointment will further strengthen the Board as the Company advances its strategy in Venezuela. Based in London, Chris is an American Geologist and highly experienced energy executive who spent 43 years at Chevron (and Texaco) in various roles ranging from technical to commercial. In his most recent role as Director of Commercial (E&P Americas), he led Chevron’s Venezuela sanctions effort.
Comment: Canny investors are certainly enjoying this big wig appointment to a just £20m market cap company. While the shares are already up 10x in their new incarnation, today’s news promises that we are only at the foothills of the rally and that a return to last month’s 180p peak is perfectly possible before the summer is over.
Cizzle Biotechnology (CIZ), the UK based diagnostics developer of early cancer tests, announced an operational update and highlights for the six months ended 30 June 2026 . CIZ said “The first half of 2026 represents probably the most important period in Cizzle’s development since the Company was founded. Our focus has been on transitioning from technology development and validation to commercial deployment, and we have delivered significant milestones towards that objective. Most notably, the achievement of CLIA accreditation for our CIZ1B biomarker test represents the point at which our proprietary technology can begin to be used in routine clinical practice in the United States. This is a major validation of both the science underpinning our technology and the significant work undertaken alongside our licensing partner BIO.”
Comment: At least in share price terms CIZ remains a frustrating situation, once again having its share price back down from the main 3p resistance area. What will be key in the stock achieving the big breakthrough we have been waiting for will be how quickly the company can commercialise its efforts in the all-important US market.
CelLBxHealth plc (CLBX), a CTC intelligence company specialising in innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, announced its unaudited Q2 and the interim results for the six months ended 30 June 2026. CelLBxHealth Executive Chairman, Jan Groen, commented: “We have created a leaner, more commercially focused business, strengthened our strategic partnerships and the strong growth in Q2 revenue is an early sign of the successful implementation of our revised commercial strategy. Our unique live CTC platform addresses an important unmet clinical need, and we remain focused on disciplined execution as we convert this growing opportunity into sustainable revenue growth.”
Comment: CLBX continues to be one of the better mini-biotech hopes on the London market. Ideally, the market will cotton onto this in coming months and serve up the at least a retest of May peaks for the shares through 2.5p as we head into the autumn.
Cohort (CHRT) today announced its audited results for the financial year ended 30 April 2026. CHRT said “Cohort continues to see strong demand for our products and services from both our domestic and export customers, reflecting our strong and relevant offerings in NATO Europe and elsewhere. Overall demand has been driven by the conflicts in Ukraine and the Middle East, persistent tensions in the Asia-Pacific Region and pressure from the United States administration on the other members of NATO to increase their defence spending. We are also encouraged by the UK DIP’s emphasis on relevant technology areas including the hybrid navy, Atlantic Bastion, and protection of underwater infrastructure.”
Comment: The strong update reminding the market of its fundamental credentials, we should expect to see shares of CHRT break out of their recent £11 – £15 range over the course of the rest of H2 2026. The company remains a decent play on the ongoing geopolitical shenanigans we are being subjected to.
Kendrick Resources (KEN) reported strong portable X-ray fluorescence (“pXRF”) surface channel sample results from five carbonatite bodies (TKCH001 to TKCH005) at Teufelskuppe (“TK”), confirming extensive and continuous, high-grade light rare earth oxide mineralisation over substantial widths. The results reinforce TK’s potential as a significant rare earth element (“REE”) project, with representative channel sampling across all five exposed carbonatite bodies demonstrating continuous and pervasive LREO mineralisation consistent with the Company’s drilling results.
Comment: KEN continues to remind the market regarding its REE credentials, something which should be enough to revive the mega rally in the shares which took them on a record bull run from the turn of the year until May. Having bounced off 5p after a 10p peak, the shares should now be on their way.
Yellow Cake (YCA) announced its Annual Results for the year ended 31 March 2026. YCA said “ I am pleased to report that Yellow Cake has continued to deliver on our stated strategy. We successfully raised approximately USD283 million during the financial year, enabling us to exercise our purchase options with Kazatomprom and grow our total holdings to 23.11 million pounds at 31 March 2026, rising to 24.37 million pounds on completion of committed purchases after the year end. By directly converting investor capital into physical inventory held for the long term, we have expanded our net assets while preserving a low-cost, debt-free structure. As the term market continues to tighten, we remain highly confident in our model, which provides investors with direct exposure to the uranium price.”
Comment: YCA remains a company with a strong cash position in a strong space, boosted by the AI fuelled data centre boom. Given the way that the market conditions to allow the shares to trade at both a discount to NAV and the last placing, one can say that entering the fray here appears to be a sensible thing to do.
Zenith Energy Ltd (ZEN) announced that it has signed a Memorandum of Understanding (the “MoU“) with a renewable energy operator for the sale of a portfolio of solar development projects located in the Piedmont region of Italy, with an aggregate expected installed capacity of approximately 50 MWp, for a total consideration of EUR 12 million. The projects comprising the South Piedmont Portfolio have been assembled and advanced by Zenith over the past year through a series of acquisitions and development activities. The aggregate acquisition and development cost of the Piedmont Portfolio is expected to be approximately EUR 5 million upon completion, implying a gross profit of approximately EUR 7 million on the Proposed Transaction. The MoU follows the Company’s announcement on July 13, 2026, that it was in advanced discussions regarding the disposal of a solar development project and, if completed, would represent the first monetisation of Zenith’s Italian solar portfolio.
Comment: If the market seems content to ignore the potential of a bumper arbitration win, it should be less coy about ZEN’s ongoing renewable energy strategy at a time of renewed oil price strength. Today’s MoU announcement underlines the way that ZEN is building a significant portfolio in this space.
Disclaimer & Declaration of Interest:
The information, investment views, and recommendations in this Zaks Traders Cafe interview are provided for general information purposes only. Nothing in this interview should be construed as a promotion or solicitation to buy or sell any financial product relating to any companies under discussion or referred to or to engage in or refrain from doing so or engage in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.
